You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Litigation Details for Omeros Corporation v. Sandoz Inc. (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Omeros Corporation v. Sandoz Inc. (D. Del. 2017)

Docket	⤷ Try a Trial	Date Filed	2017-06-21
Court	District Court, D. Delaware	Date Terminated	2018-07-25
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	OMEROS CORPORATION
Patents	8,173,707; 8,586,633; 9,066,856; 9,278,101; 9,399,040; 9,486,406; 9,855,246
Attorneys	Keith D. Parr
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Small Molecule Drugs cited in Omeros Corporation v. Sandoz Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .

Details for Omeros Corporation v. Sandoz Inc. (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2018-01-31	38		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,855,246 B2; . (Noreika, Maryellen…2017 25 July 2018 1:17-cv-00799 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2017-06-21	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,173,707 B2; 8,586,633 B2; 9,066,856…2017 25 July 2018 1:17-cv-00799 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-03-05	46		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,855,246 B2; . (Noreika, Maryellen…2017 25 July 2018 1:17-cv-00799 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-07-24	71	Stipulation of Dismissal	Paragraph III Certification with respect to U.S. Patents 8,173,707; 8,586,633; 9,066,856; 9,278,101…submitted a patent amendment to its pending ANDA 207841 in which it revised its Patent and Exclusivity… after the expiration of these patents, this action and all claims and defenses asserted…2017 25 July 2018 1:17-cv-00799 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-07-25	72	Order	Paragraph III Certification with respect to U.S. Patents 8,173,707; 8,586,633; 9,066,856; 9,278,101…submitted a patent amendment to its pending ANDA 207841 i.n which it revised its Patent and Exclusivity… after the expiration of these patents, this action and all claims and defenses asserted…2017 25 July 2018 1:17-cv-00799 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.